These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20937561)

  • 21. Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.
    Lee J; Jin MK; Kang SU; Kim SY; Lee J; Shin M; Hwang J; Cho S; Choi YS; Choi HK; Kim SE; Suh YG; Lee YS; Kim YH; Ha HJ; Toth A; Pearce LV; Tran R; Szabo T; Welter JD; Lundberg DJ; Wang Y; Lazar J; Pavlyukovets VA; Morgan MA; Blumberg PM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4143-50. PubMed ID: 15993063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor.
    Lee J; Lee J; Kang M; Shin M; Kim JM; Kang SU; Lim JO; Choi HK; Suh YG; Park HG; Oh U; Kim HD; Park YH; Ha HJ; Kim YH; Toth A; Wang Y; Tran R; Pearce LV; Lundberg DJ; Blumberg PM
    J Med Chem; 2003 Jul; 46(14):3116-26. PubMed ID: 12825950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chimeric approach reveals that differences in the TRPV1 pore domain determine species-specific sensitivity to block of heat activation.
    Papakosta M; Dalle C; Haythornthwaite A; Cao L; Stevens EB; Burgess G; Russell R; Cox PJ; Phillips SC; Grimm C
    J Biol Chem; 2011 Nov; 286(45):39663-72. PubMed ID: 21911503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulation.
    Blumberg PM; Pearce LV; Lee J
    Curr Top Med Chem; 2011; 11(17):2151-8. PubMed ID: 21671879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of indane propanamides as potent and selective TRPV1 antagonists.
    Ahn S; Kim YS; Kim MS; Ann J; Ha H; Yoo YD; Kim YH; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126838. PubMed ID: 31864799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
    Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
    J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of 2-(3,5-difluoro-4-methylsulfonaminophenyl)propanamides as potent TRPV1 antagonists.
    Kim C; Ann J; Lee S; Sun W; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2539-2542. PubMed ID: 29884534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists.
    Gore VK; Ma VV; Tamir R; Gavva NR; Treanor JJ; Norman MH
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5825-30. PubMed ID: 17851073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1.
    Lizanecz E; Bagi Z; Pásztor ET; Papp Z; Edes I; Kedei N; Blumberg PM; Tóth A
    Mol Pharmacol; 2006 Mar; 69(3):1015-23. PubMed ID: 16338989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region.
    Kim YS; Kil MJ; Kang SU; Ryu H; Kim MS; Cho Y; Bhondwe RS; Thorat SA; Sun W; Liu K; Lee JH; Choi S; Pearce LV; Pavlyukovets VA; Morgan MA; Tran R; Lazar J; Blumberg PM; Lee J
    Bioorg Med Chem; 2012 Jan; 20(1):215-24. PubMed ID: 22169633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
    Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
    Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl)methyl) ureas as potent and thermoneutral TRPV1 antagonists.
    Kang JM; Kwon SO; Ann J; Blumberg PM; Ha H; Yoo YD; Frank-Foltyn R; Lesch B; Bahrenberg G; Stockhausen H; Christoph T; Lee J
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127548. PubMed ID: 32931910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts.
    Tsumura M; Sobhan U; Muramatsu T; Sato M; Ichikawa H; Sahara Y; Tazaki M; Shibukawa Y
    Cell Calcium; 2012 Aug; 52(2):124-36. PubMed ID: 22656960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1).
    Jetter MC; McNally JJ; Youngman MA; McDonnell ME; Dubin AE; Nasser N; Zhang SP; Codd EE; Colburn RW; Stone DR; Brandt MR; Flores CM; Dax SL
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2730-4. PubMed ID: 18359227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies.
    Lee JH; Lee Y; Ryu H; Kang DW; Lee J; Lazar J; Pearce LV; Pavlyukovets VA; Blumberg PM; Choi S
    J Comput Aided Mol Des; 2011 Apr; 25(4):317-27. PubMed ID: 21448716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High affinity antagonists of the vanilloid receptor.
    Wang Y; Szabo T; Welter JD; Toth A; Tran R; Lee J; Kang SU; Suh YG; Blumberg PM; Lee J
    Mol Pharmacol; 2002 Oct; 62(4):947-56. PubMed ID: 12237342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SAR analysis of TRPV1 agonists with the α-methylated B-region.
    Cho Y; Kim MS; Kim HS; Ann J; Lee J; Pearce LV; Pavlyukovets VA; Morgan MA; Blumberg PM; Lee J
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5227-31. PubMed ID: 22796184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, photolysis studies and in vitro photorelease of caged TRPV1 agonists and antagonists.
    Van Ryssen MP; Avlonitis N; Giniatullin R; McDougall C; Carr JL; Stanton-Humphreys MN; Borgström EL; Brown CT; Fayuk D; Surin A; Niittykoski M; Khiroug L; Conway SJ
    Org Biomol Chem; 2009 Nov; 7(22):4695-707. PubMed ID: 19865707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1.
    Marincsák R; Tóth BI; Czifra G; Szabó T; Kovács L; Bíró T
    Anesth Analg; 2008 Jun; 106(6):1890-6. PubMed ID: 18499628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evodiamine functions as an agonist for the vanilloid receptor TRPV1.
    Pearce LV; Petukhov PA; Szabo T; Kedei N; Bizik F; Kozikowski AP; Blumberg PM
    Org Biomol Chem; 2004 Aug; 2(16):2281-6. PubMed ID: 15305207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.